参考文献/References:
[1] Shi S,Tang Y,Zhao Q,et al. Prevalence and risk of atrial fibrillation in China:a national cross-sectional epidemiological study[J]. Lancet Reg Health West Pac,2022,23:100439.
[2] Volgman AS,Nair G,Lyubarova R,et al. Management of atrial fibrillation in patients 75 years and older:JACC state-of-the-art review[J]. J Am Coll Cardiol,2022,79(2):166-179.
[3] Bencivenga L,Komici K,Nocella P,et al. Atrial fibrillation in the elderly:a risk factor beyond stroke[J]. Ageing Res Rev,2020,61:101092.
[4] Nattel S,Heijman J,Zhou L,et al. Molecular basis of atrial fibrillation pathophysiology and therapy:a translational perspective[J]. Circ Res,2020,127(1):51-72.
[5] Pan Y,Xu L,Yang X,et al. The common characteristics and mutual effects of heart failure and atrial fibrillation:initiation,progression,and outcome of the two aging-related heart diseases[J]. Heart Fail Rev,2021,27(3):837-847.
[6] 麦麦提阿卜杜拉·麦麦提敏,张玲,曹桂秋,等.不同频率心房电刺激对犬急性房颤模型的心房电重构影响及安全性分析[J].新疆医科大学学报2022,45(10):1116-1121,1128.
[7] 程新春,张玲,周贤惠,等.增龄对房颤犬心房有效不应期的影响[J].新疆医科大学学报2018,41(7):816-819.
[8] Zhang L,Ye K,Xiaokereti J,et al. Histopathological substrate of the atrial myocardium in the progression of obstructive sleep apnoea–related atrial fibrillation[J]. Sleep Breath,2021,25(2):807-818.
[9] Heijman J,Guichard JB,Dobrev D,et al. Translational challenges in atrial fibrillation[J]. Circ Res,2018,122(5):752-773.
[10] Li J,Solus J,Chen Q,et al. Role of inflammation and oxidative stress in atrial fibrillation[J]. Heart Rhythm,2010,7(4):438-444.
[11] Lin PH,Lee SH,Su CP,et al. Oxidative damage to mitochondrial DNA in atrial muscle of patients with atrial fibrillation[J]. Free Radic Biol Med,2003,35(10):1310-1318.
[12] Chimenti C,Russo MA,Carpi A,et al. Histological substrate of human atrial fibrillation[J]. Biomed Pharmacother,2010,64(3):177-183.
[13] Jesel L,Abbas M,Park SH,et al. Atrial fibrillation progression is associated with cell senescence burden as determined by p53 and p16 expression[J]. J Clin Med,2019,9(1):36.
[14] Lu Z,Scherlag BJ,Lin J,et al. Atrial fibrillation begets atrial fibrillation:autonomic mechanism for atrial electrical remodeling induced by short-term rapid atrial pacing[J]. Circ Arrhythm Electrophysiol,2008,1(3):184-192.
[15] Gao XY,Lai YY,Luo XS,et al. Acetyltransferase p300 regulates atrial fibroblast senescence and age-related atrial fibrosis through p53/Smad3 axis[J]. Aging Cell,2023,22(1):e13743.
[16] Kirschner Peretz N,Segal S,Shapira R,et al. Changes in cAMP signaling are associated with age-related downregulation of spontaneously beating atrial tissue energetic indices[J]. Geroscience,2023,45(1):209-219.
相似文献/References:
[1]贺鹏康,周菁.心房颤动治疗新技术——冷冻球囊消融[J].心血管病学进展,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
HE Pengkang,ZHOU Jing.Cryoballoon Ablation, A Novel Technology for Atrial Fibrillation Treatment[J].Advances in Cardiovascular Diseases,2016,(2):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
[2]都明辉,施海峰*,佟佳宾,等.心房颤动消融相关性无症状性脑缺血[J].心血管病学进展,2016,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
DU Minghui,SHI Haifeng*,TONG Jiabin,et al.Silent Cerebral Ischemia Related to Atrial Fibrillation Ablation[J].Advances in Cardiovascular Diseases,2016,(2):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
[3]郑环杰,综述,肖骅,等.心房颤动抗栓治疗研究进展[J].心血管病学进展,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
ZHENG Huanjie,XIAO Hua.Progress of Antithrombotic Therapy in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
[4]张清,综述,罗素新,等.新型Xa 因子抑制剂———依度沙班在心房颤动患者抗凝治疗中的研究进展[J].心血管病学进展,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
ZHANG Qing,LUO Suxin,TANG Jiong.Novel Factor Xa Inhibitors—Edoxaban in Prevention of Stroke in
Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
[5]胡红玲,综述,罗素新,等.预防非瓣膜性心房颤动性脑卒中的治疗新进展[J].心血管病学进展,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
HU Hongling,LUO Suxin.New Progress in the Treatment for Cerebral Apoplexy of Nonvalvular
Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(2):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
[6]王超,杨国澍,综述,等.关附甲素治疗心房颤动的研究进展[J].心血管病学进展,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
WANG Chao,YANG Guoshu,CAI Lin,et al.Research Progress of the Treatment of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(2):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
[7]徐小东,综述,杨东辉,等.决奈达隆治疗心房颤动的现状及展望[J].心血管病学进展,2016,(4):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
XU Xiaodong,YANG Donghui.Status and Prospect of Dronedarone in Treating Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(2):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
[8]张莎,储国俊,吴弘.经导管左心耳封堵术的临床应用进展[J].心血管病学进展,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
ZHANG Sha,CHU Guojun,WU Hong.Clinial Application Advances in Left Atrial Appendage Closure[J].Advances in Cardiovascular Diseases,2015,(2):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
[9]汪俊,杨浩.心房颤动射频消融的术式演变[J].心血管病学进展,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
WANG Jun,YANG Hao.Evolution of Radiofrequency Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2015,(2):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
[10]赵璐,苏立.心房颤动与离子通道重构研究进展[J].心血管病学进展,2015,(5):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
ZHAO Lu,SU Li.Research Progress of Atrial Fibrillation and Ion Channel Remodeling[J].Advances in Cardiovascular Diseases,2015,(2):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]